The Patent Finder
US

Milnacipran for the Long-Term Treatment of Fibromyalgia Syndrome

US 7,994,220 In force
OverviewAssignmentsSources & methods

Also listed on Forest Laboratories Holdings Unlimited Company, an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Sep 19, 2029 · High confidence

Filed Sep 26, 2006 as application 11/535,237 · Granted Aug 9, 2011
Base term plus 1089 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2006 2029
Clock starts
Sep 26, 2006
Term ends
Sep 19, 2029
Granted
Aug 9, 2011
base term patent term adjustment fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,089
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.

This patent's term runs 1089 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Sep 26, 2006, when this application, 11/535,237, was filedSep 26, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+1089 days, USPTO patent term adjustment recordSep 19, 2029High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderSep 19, 2029High confidence

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Nov 20, 2006
Reel 18556, frame 127
Rao, Srinivas G.; Gendreau, R. Michael; Kranzler, Jay D.Cypress Bioscience Inc.Assignment of Assignor's Interest
Jul 29, 2013
Reel 30892, frame 890
Cypress Bioscience, Inc.Savella Aiv LLCAssignment of Assignor's Interest
Jul 29, 2013
Reel 30892, frame 966
Savella Aiv LLCRoyalty Pharma Collection TrustAssignment of Assignor's Interest
Mar 21, 2017
Reel 41668, frame 583
Royalty Pharma Collection TrustForest Laboratories Holdings LimitedAssignment of Assignor's Interest
Jul 8, 2024
Reel 68218, frame 582
Forest Laboratories Holdings LimitedForest Laboratories Holdings Unlimited CompanyChange of Name
Jul 8, 2024
Reel 68218, frame 611
Forest Laboratories Holdings UnlimitedAllergan Pharmaceuticals International LimitedMerger

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited